Onderneming ESSA Pharma Inc Toronto S.E.
Aandelen
EPI
CA29668H1047
Biotechnologie & Medisch Onderzoek
Vakgebied
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
David Parkinson
CEO | Chief Executive Officer | 73 | 24-06-15 |
David Wood
DFI | Director of Finance/CFO | 66 | 01-10-13 |
Peter Virsik
COO | Chief Operating Officer | - | 01-08-16 |
Chief Tech/Sci/R&D Officer | 63 | 15-07-19 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Franklin Berger
BRD | Director/Board Member | 74 | 05-03-15 |
Sanford Zweifach
BRD | Director/Board Member | 68 | 31-07-19 |
Richard Glickman
CHM | Chairman | 65 | 01-10-10 |
Director/Board Member | 55 | 31-07-19 | |
Scott Requadt
BRD | Director/Board Member | 56 | 14-01-16 |
David Parkinson
CEO | Chief Executive Officer | 73 | 24-06-15 |
Philip Kantoff
BRD | Director/Board Member | 69 | 13-09-22 |
Ann Thorell
BRD | Director/Board Member | 56 | 31-07-19 |
Gary Sollis
BRD | Director/Board Member | 69 | 26-04-12 |
Lauren Merendino
BRD | Director/Board Member | 49 | 06-06-23 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 44 238 147 | 43 230 993 ( 97,72 %) | 0 | 97,72 % |
Bedrijfsgegevens
Sector
Vaira. 1 jan. | Kapi. | |
---|---|---|
+17,96% | 44,96 mld. | |
+1,17% | 42,65 mld. | |
+48,77% | 41,85 mld. | |
-4,27% | 29,04 mld. | |
+11,42% | 26,08 mld. | |
-21,39% | 19,03 mld. | |
+4,86% | 12,75 mld. | |
+27,29% | 12,06 mld. | |
-3,50% | 11,75 mld. |